BRPI0822637A2 - Uso de lanosta-8, 24-dien-3-óis - Google Patents
Uso de lanosta-8, 24-dien-3-óisInfo
- Publication number
- BRPI0822637A2 BRPI0822637A2 BRPI0822637-7A BRPI0822637A BRPI0822637A2 BR PI0822637 A2 BRPI0822637 A2 BR PI0822637A2 BR PI0822637 A BRPI0822637 A BR PI0822637A BR PI0822637 A2 BRPI0822637 A2 BR PI0822637A2
- Authority
- BR
- Brazil
- Prior art keywords
- lanosta
- dien
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/568—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
- A61K31/569—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone substituted in position 17 alpha, e.g. ethisterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2008/002051 WO2010015874A1 (en) | 2008-08-05 | 2008-08-05 | Pharmaceutical uses of lanosta-8,24-dien-3-ols |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0822637A2 true BRPI0822637A2 (pt) | 2015-06-16 |
Family
ID=40210741
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0822637-7A BRPI0822637A2 (pt) | 2008-08-05 | 2008-08-05 | Uso de lanosta-8, 24-dien-3-óis |
Country Status (17)
Country | Link |
---|---|
US (1) | US9238036B2 (pt) |
EP (1) | EP2323666B1 (pt) |
JP (1) | JP5579181B2 (pt) |
KR (1) | KR101496507B1 (pt) |
CN (1) | CN102112133B (pt) |
AU (1) | AU2008360329B2 (pt) |
BR (1) | BRPI0822637A2 (pt) |
CA (1) | CA2732850C (pt) |
DK (1) | DK2323666T3 (pt) |
ES (1) | ES2619505T3 (pt) |
IL (1) | IL211062A (pt) |
MX (1) | MX2011001411A (pt) |
NZ (1) | NZ590233A (pt) |
PT (1) | PT2323666T (pt) |
RU (1) | RU2476226C2 (pt) |
WO (1) | WO2010015874A1 (pt) |
ZA (1) | ZA201100119B (pt) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011086424A1 (en) * | 2010-01-15 | 2011-07-21 | Amazonia Fitomedicamentos Ltda | Pharmaceutical use of multicyclic compounds mixtures as concomitant anti-cancer, anti-inflammatory and anti-pain agents |
US20130332421A1 (en) * | 2012-06-06 | 2013-12-12 | International Business Machines Corporation | Defining Content Retention Rules Using a Domain-Specific Language |
KR20170048426A (ko) * | 2014-08-22 | 2017-05-08 | 광저우 캉루이 바이오로지컬 파마슈티컬 테크놀로지 씨오., 엘티디. | 시각 장애를 치료하기 위한 조성물 및 방법 |
CN109481392B (zh) * | 2015-09-02 | 2021-12-24 | 盛世泰科生物医药技术(苏州)有限公司 | 一种用于预防和治疗白内障的眼用制剂及其制备方法 |
WO2023147640A1 (en) * | 2022-02-07 | 2023-08-10 | GERVÁSIO ALVES DA SILVA, Társis | Preparation of novel triterpene alcohol derivatives with enhanced bioavailability for cancer, inflammation and pain treatment |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR179F (pt) * | 1963-09-12 | |||
US3625954A (en) * | 1968-03-20 | 1971-12-07 | Pfizer | 1-aroylbenzimidazoles |
DE10155200A1 (de) * | 2001-11-12 | 2003-05-28 | Skinlab Gmbh | Verwendung von Cholesterin, cholesterinhaltigen Substanzen oder von den Cholesteringehalt erhöhenden Substanzen in kosmetischen und dermatologischen Zubereitungen zum Zwecke der UV-Protektion |
WO2006007676A1 (en) | 2004-07-21 | 2006-01-26 | Amazônia Fitomedicamentos Ltda. | Combination of active fractions from the plants euphorbia tirucalli l and ficos carica l. and method of treating cancer and aids |
-
2008
- 2008-08-05 NZ NZ590233A patent/NZ590233A/xx not_active IP Right Cessation
- 2008-08-05 RU RU2011108558/15A patent/RU2476226C2/ru active
- 2008-08-05 CA CA2732850A patent/CA2732850C/en not_active Expired - Fee Related
- 2008-08-05 EP EP08789007.5A patent/EP2323666B1/en not_active Not-in-force
- 2008-08-05 KR KR1020117002127A patent/KR101496507B1/ko active IP Right Grant
- 2008-08-05 WO PCT/IB2008/002051 patent/WO2010015874A1/en active Application Filing
- 2008-08-05 BR BRPI0822637-7A patent/BRPI0822637A2/pt not_active Application Discontinuation
- 2008-08-05 ES ES08789007.5T patent/ES2619505T3/es active Active
- 2008-08-05 CN CN2008801307081A patent/CN102112133B/zh not_active Expired - Fee Related
- 2008-08-05 PT PT87890075T patent/PT2323666T/pt unknown
- 2008-08-05 DK DK08789007.5T patent/DK2323666T3/en active
- 2008-08-05 JP JP2011521646A patent/JP5579181B2/ja not_active Expired - Fee Related
- 2008-08-05 AU AU2008360329A patent/AU2008360329B2/en not_active Ceased
- 2008-08-05 MX MX2011001411A patent/MX2011001411A/es active IP Right Grant
- 2008-08-05 US US13/057,250 patent/US9238036B2/en not_active Expired - Fee Related
-
2011
- 2011-01-05 ZA ZA2011/00119A patent/ZA201100119B/en unknown
- 2011-02-03 IL IL211062A patent/IL211062A/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
EP2323666B1 (en) | 2017-01-04 |
JP5579181B2 (ja) | 2014-08-27 |
AU2008360329A2 (en) | 2011-06-16 |
US20110136773A1 (en) | 2011-06-09 |
MX2011001411A (es) | 2011-03-15 |
JP2011529956A (ja) | 2011-12-15 |
DK2323666T3 (en) | 2017-04-10 |
CN102112133B (zh) | 2013-05-08 |
US9238036B2 (en) | 2016-01-19 |
CA2732850C (en) | 2016-06-21 |
CA2732850A1 (en) | 2010-02-11 |
RU2011108558A (ru) | 2012-09-10 |
EP2323666A1 (en) | 2011-05-25 |
ZA201100119B (en) | 2012-03-28 |
KR20110044984A (ko) | 2011-05-03 |
PT2323666T (pt) | 2017-04-06 |
IL211062A (en) | 2015-02-26 |
KR101496507B1 (ko) | 2015-03-03 |
RU2476226C2 (ru) | 2013-02-27 |
NZ590233A (en) | 2012-10-26 |
IL211062A0 (en) | 2011-04-28 |
AU2008360329B2 (en) | 2014-07-31 |
CN102112133A (zh) | 2011-06-29 |
AU2008360329A1 (en) | 2010-02-11 |
ES2619505T3 (es) | 2017-06-26 |
WO2010015874A1 (en) | 2010-02-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO2021006I1 (no) | Quofenix, delafloksacin | |
BR112012002349A2 (pt) | composto,e, uso do mesmo | |
BRPI0821668A2 (pt) | Uso | |
BRPI1012533A2 (pt) | composto de piradazinona e uso do mesmo | |
BRPI0921327A2 (pt) | Combinação de herbicida-protetor | |
BRPI0915134A2 (pt) | composto, e, uso de um composto | |
BRPI0911695A2 (pt) | conjunto de barbear | |
BRPI0907376A2 (pt) | Fotobiorretador | |
BRPI0921389A2 (pt) | seringa de um só uso, de inutilização automática | |
BRPI0813627A2 (pt) | Peptídio antimicrobiano, composições e métodos de uso | |
BRPI0915086A2 (pt) | detecção do uso de canabis | |
BRPI0823082A2 (pt) | Uso derivados de sesquiterpeno | |
BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
DE112009000578A5 (de) | Reibahle | |
BRPI0913234A2 (pt) | derivados de tiazolilpiperidina | |
BRPI1011036A2 (pt) | uso | |
BRPI1006996A2 (pt) | composição, método e uso | |
BRPI0907522A2 (pt) | biarlamidas | |
BRPI0913267A2 (pt) | uso do ácido succínico | |
BRPI0922728A2 (pt) | combinação de herbicida-antídoto | |
BRPI0922652A2 (pt) | Derivados de quinazolinamida | |
BRPI0907863A2 (pt) | pirrolopirimidinacarboxamidas | |
BRPI0909634A2 (pt) | 2-aminoquinolinas | |
BRPI0909223A2 (pt) | uso de catepsaina c |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] | ||
B12B | Appeal against refusal [chapter 12.2 patent gazette] |